Advances in the adjuvant and neoadjuvant treatment of breast cancer

Author： Briest Susanne   Stearns Vered  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.3, Iss.3, 2007-05, pp. : 325-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

T-DM1 in the Neo-Adjuvant Treatment of HER2-Positive Breast Cancer: Impact of the KRISTINE (TRIO-021) Trial

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 3, 2017-11 ,pp. : 216-222

Bentham Science Publishers

Access to resources Recommend Favorite

Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 5, 2015-05 ,pp. : 315-320

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant Endocrine Treatment in Premenopausal Early Breast Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 9-13

Karger

Access to resources Recommend Favorite

Neoadjuvant and Adjuvant Chemotherapy of Cervical Cancer

By  

Oncology Research and Treatment, Vol. 39, Iss. 9, 2016-08 ,pp. : 522-524

Karger

Access to resources Recommend Favorite

Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2‐positive metastatic breast cancer

By  

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 1932-1938

John Wiley & Sons Inc

Access to resources Recommend Favorite